DENIS ADAMS: Open Payments
NPI 1174501811 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,528 in 126 payments from 18 companies in 2025. Trend: 2023 $2,664 · 2024 $2,736 · 2025 $2,528
Food & beverage: $2,333Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $446 |
| ABBVIE INC. | 25 | $383 |
| Regeneron Healthcare Solutions, Inc. | 12 | $355 |
| GENZYME CORPORATION | 10 | $222 |
| Lilly USA, LLC | 9 | $182 |
| Galderma Laboratories, L.P. | 13 | $167 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $143 |
| Organon LLC | 6 | $105 |
| PFIZER INC. | 5 | $102 |
| UCB, Inc. | 4 | $73 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, NEMLUVIO, TALTZ, LIBTAYO, CIBINQO.
Industry payments across TX — which companies pay providers there.
